CLINICAL_TRIALS
trial_result
· 2015-03-06
Clinical Trial Update: An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors [Phase 1]
Summary
Open-label Phase I dose-escalation study of E7080 (lenvatinib) in patients with solid tumors; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Cancer: Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2015-03-06